- Vol 37, Issue 4
- Volume 37
- Issue 4
Let’s Talk About Resilience
Psychiatry is in a unique position to help the world navigate these unprecidented times. MJH Life Sciences' founder and CEO introduces the newest issue of Psychiatric Times.
FROM THE CHAIRMAN OF MJH LIFE SCIENCES
As I write this, the world is dealing with an unprecedented crisis.
Psychiatry’s focus on recovery and resilience allows for a positive approach to challenges. Psychiatrists have been on the forefront of dealing with disasters and learning from them, so they can not only help their patients but society as a whole. Along those lines, Phebe Tucker, MD, shares a
Similarly,
And so, we continue to march forward, meeting our daily challenges despite this new crisis. Your patients continue to need care, perhaps now more than ever, and Psychiatric Times is here to support you in that endeavor.
David Osser, MD,
You will also find our
We hope you and yours remain safe, well, and resilient during these challenging times!
Mike Hennessy Sr
Chairman and Founder, MJH Life Sciences, parent company of Psychiatric Times
Articles in this issue
over 5 years ago
The Name “Schizophrenia” Is Heard Worldwideover 5 years ago
Big Brother FDA Is Watching, Helpingover 5 years ago
Drug Receptor Profiles Matterover 5 years ago
The Other #MeToo: Male Sexual Abuse Survivorsover 5 years ago
25 Years After the Oklahoma City Bombingover 5 years ago
Resilience, Not Panic, in a Time of Pandemicover 5 years ago
What Is the Deal With Esketamine?Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.











